Illustration showing repaglinide (white, blue and red spheres within helices) binding to an ATP-dependent potassium channel (multicoloured helices) on a pancreatic beta cell. Repaglinide belongs to a class of drug known as meglitinides which bind to ATP-dependent potassium channels in pancreatic beta cells, stimulating insulin release. Insulin, in turn, increases cellular glucose uptake, reducing blood sugar levels, making repaglinide a suitable treatment for type 2 diabetes.
| px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP29693959
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images:
actionantidiabeticartworkatp-dependentpotassiumchannelbetacellbindingbiochemicalbiochemistrybiologicalbiologybloodglucoseregulationbloodsugarregulationboundcellmembranecgichemicalchemistrycompounddiabetesdigitallygenerateddrugendocrineendocrinologicalendocrinologyenyglidgluconormhormoneillustrationkchannelmechanismofactionmedicalmedicationmedicinemeglitinidemeglitinidesmolecularbiologymolecularmodelmolecularstructuremoleculeno-onenobodynovonormpancreaspancreaticpeptidephospholipidbilayerpiperidinesprandinrepagliniderpgstickandballmodelsureposttransmembranereceptortreatmentyellowbackground
actionactionandantidiabeticartworkatp-dependentbackgroundballbetabilayerbindingbiochemicalbiochemistrybiologicalbiologybiologybloodbloodboundcellcellcgichannelchannelchemicalchemistrycompounddiabetesdigitallydrugendocrineendocrinologicalendocrinologyenyglidgeneratedgluconormglucosehormoneillustrationkmechanismmedicalmedicationmedicinemeglitinidemeglitinidesmembranemodelmodelmolecularmolecularmolecularmoleculeno-onenobodynovonormofpancreaspancreaticpeptidephospholipidpiperidinespotassiumprandinreceptorregulationregulationrepagliniderpgstickstructuresugarsureposttransmembranetreatmentyellow
Loading